Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunocore Holdings plc

IMCR Clue Score48
United Kingdom Fiscal year ends December CIK 0001671927 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David M Berman
5 Dec 2025
Head of R&D
Sold after exercise
572
$40.14
$22.96K
David M Berman
4 Dec 2025
Head of R&D
Sold after exercise
31,341
$40.26
$1.26M
David M Berman
28 Nov 2025
Head of R&D
Sold after exercise
5,521
$40.09
$221.34K
David M Berman
26 Nov 2025
Head of R&D
Sold after exercise
69,404
$40.12
$2.78M
David M Berman
25 Nov 2025
Head of R&D
Sold after exercise
18,020
$40.03
$721.34K
David M Berman
24 Nov 2025
Head of R&D
Sold after exercise
100
$40.00
$4.00K

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 6
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 164,069
History held since 5 Jan 2024